Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients

  • Author: José R. Arribas, MD (More Info)
  • Section Editor: Eric S. Daar, MD
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 10/12/18 (What's New)

Summary

  • Another strategy to maintain suppression but minimize toxicity and cost is to switch to dual therapy with a ritonavir-boosted PI plus a single NRTI
  • The use of dual atazanavir plus ritonavir plus lamivudine therapy for maintenance of viral suppression has been evaluated in several trials

Action required